References
- Russo RAG, Katsicas MM. Takayasu arteritis. Front Pediatr. 2018;6:265. doi:10.3389/fped.2018.00265
- Chaudhry MA, Latif F. Takayasu’s arteritis and its role in causing renal artery stenosis. Am J Med Sci. 2013;346(4):314–318. doi:10.1097/MAJ.0b013e31827e5dad
- Domek M, Gumprecht J, Lip GYH, Shantsila A. Malignant hypertension: does it still exist? J Hum Hypertens. 2020;34:1–4. doi:10.1038/s41371-019-0267-y
- Shigabaki Y, Fujita T. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other? Hypertens Res. 2005;28(1):89–95. doi:10.1291/hypres.28.89
- Li Cavoli G, Mulè G, Vallone MG, Caputo F. Takayasu’s disease effects on the kidneys: current perspectives. Int J Nephrol Renovasc Dis. 2018;11:225–233. doi:10.2147/IJNRD.S146355
- Wolak T, Szendro G, Golcman L, Paran E. Malignant hypertension as a presenting symptom of Takayasu arteritis. Mayo Clin Proc. 2003;78(2):231–236. doi:10.4065/78.2.231
- Patel B, Tiwari A, Dubey SR, Bhatt GC, Tiwari P, Bhan BD. Takayasu arteritis presenting with malignant hypertension; a rare manifestation of a rare disease: a case report and review of literature. Trop Doc. 2017;47(1):60–63. doi:10.1177/0049475516648062